Vermillion Announces Date Change Of Second Quarter 2017 Financial Results And Investor Conference Call
AUSTIN, Texas, Aug. 4, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will now report its second quarter 2017 financial results on Wednesday, August 9, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.
Wednesday, August 9th @ 4:30pm Eastern Time | |
Domestic: | 888-437-9274 |
International: | 719-325-2437 |
Conference ID: | 8515049 |
Webcast: | |
Replays, Available through August 23nd | |
Domestic: | 844-512-2921 |
International: | 412-317-6671 |
Replay PIN: | 8515049 |
About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.
Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com
View original content:http://www.prnewswire.com/news-releases/vermillion-announces-date-change-of-second-quarter-2017-financial-results-and-investor-conference-call-300499863.html
SOURCE Vermillion, Inc.
